메뉴 건너뛰기




Volumn 17, Issue 1, 2009, Pages 99-102

The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: A phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial

Author keywords

5 HT3 receptor antagonist; Antiemetic; Chemotherapy induced vomiting; Granisetron; Palonosetron

Indexed keywords

CISPLATIN; CORTICOSTEROID; EPIRUBICIN; GRANISETRON; PALONOSETRON; SEROTONIN ANTAGONIST;

EID: 57849152399     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-008-0503-4     Document Type: Article
Times cited : (36)

References (11)
  • 1
    • 1942476106 scopus 로고    scopus 로고
    • Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects
    • 5
    • R Stoltz JC Cyong A Shah S Parisi 2004 Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects J Clin Pharmacol 44 5 520 531
    • (2004) J Clin Pharmacol , vol.44 , pp. 520-531
    • Stoltz, R.1    Cyong, J.C.2    Shah, A.3    Parisi, S.4
  • 2
    • 34347242123 scopus 로고    scopus 로고
    • Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: A comparison of efficacy, side-effect profile, and cost
    • 3
    • H Abali I Celik 2007 Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost Cancer Invest 25 3 135 139
    • (2007) Cancer Invest , vol.25 , pp. 135-139
    • Abali, H.1    Celik, I.2
  • 3
    • 38949173080 scopus 로고    scopus 로고
    • Current issues in non-inferiority trials
    • 3
    • TR Fleming 2008 Current issues in non-inferiority trials Stat Med 27 3 317 332
    • (2008) Stat Med , vol.27 , pp. 317-332
    • Fleming, T.R.1
  • 4
    • 0033998179 scopus 로고    scopus 로고
    • 3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting
    • 3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting Cancer Invest 18 163 173
    • (2000) Cancer Invest , vol.18 , pp. 163-173
    • Hesketh, P.J.1
  • 6
    • 0344412945 scopus 로고    scopus 로고
    • Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: Results of a phase III, single-dose trial versus dolasetron
    • 99-04 Palonosetron Study Group
    • P Eisenberg J Figueroa-Vadillo R Zamora V Charu J Hajdenberg A Cartmell A Macciocchi S Grunberg 99-04 Palonosetron Study Group 2003 Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron Cancer 98 2473 2482
    • (2003) Cancer , vol.98 , pp. 2473-2482
    • Eisenberg, P.1    Figueroa-Vadillo, J.2    Zamora, R.3    Charu, V.4    Hajdenberg, J.5    Cartmell, A.6    MacCiocchi, A.7    Grunberg, S.8
  • 7
    • 1342267601 scopus 로고    scopus 로고
    • Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: A dose-ranging clinical study
    • 2
    • P Eisenberg FR MacKintosh P Ritch PA Cornett A Macciocchi 2004 Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study Ann Oncol 15 2 330 337
    • (2004) Ann Oncol , vol.15 , pp. 330-337
    • Eisenberg, P.1    MacKintosh, F.R.2    Ritch, P.3    Cornett, P.A.4    MacCiocchi, A.5
  • 8
    • 33749640979 scopus 로고    scopus 로고
    • Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: Palonosetron, dexamethasone, and aprepitant
    • 8
    • T Grote J Hajdenberg A Cartmell S Ferguson A Ginkel V Charu 2006 Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant J Support Oncol 4 8 403 408
    • (2006) J Support Oncol , vol.4 , pp. 403-408
    • Grote, T.1    Hajdenberg, J.2    Cartmell, A.3    Ferguson, S.4    Ginkel, A.5    Charu, V.6
  • 9
    • 20444475381 scopus 로고    scopus 로고
    • Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting
    • 4
    • TH Oo PJ Hesketh 2005 Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting Nat Clin Pract Oncol 2 4 196 201
    • (2005) Nat Clin Pract Oncol , vol.2 , pp. 196-201
    • Oo, T.H.1    Hesketh, P.J.2
  • 10
    • 0028218986 scopus 로고
    • Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: A Phase III trial by the National Cancer Institute of Canada Clinical Trials Group
    • L Kaizer D Warr P Hoskins 1994 Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a Phase III trial by the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 12 1050 1057
    • (1994) J Clin Oncol , vol.12 , pp. 1050-1057
    • Kaizer, L.1    Warr, D.2    Hoskins, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.